IL147676A0 - Improvement of spermatozoa fertilization activity - Google Patents

Improvement of spermatozoa fertilization activity

Info

Publication number
IL147676A0
IL147676A0 IL14767600A IL14767600A IL147676A0 IL 147676 A0 IL147676 A0 IL 147676A0 IL 14767600 A IL14767600 A IL 14767600A IL 14767600 A IL14767600 A IL 14767600A IL 147676 A0 IL147676 A0 IL 147676A0
Authority
IL
Israel
Prior art keywords
improvement
spermatozoa
fertilization activity
spermatozoa fertilization
activity
Prior art date
Application number
IL14767600A
Other languages
English (en)
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of IL147676A0 publication Critical patent/IL147676A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fertilizers (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14767600A 1999-07-26 2000-07-25 Improvement of spermatozoa fertilization activity IL147676A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999FI000171A IT1307787B1 (it) 1999-07-26 1999-07-26 Processo per incrementare la motilita' degli spermatozoi e spermatozoia motilita' superiore cosi' ottenuti.
PCT/EP2000/007108 WO2001007021A2 (en) 1999-07-26 2000-07-25 Process for the improvement of spermatozoa fertilization activity

Publications (1)

Publication Number Publication Date
IL147676A0 true IL147676A0 (en) 2002-08-14

Family

ID=11353050

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14767600A IL147676A0 (en) 1999-07-26 2000-07-25 Improvement of spermatozoa fertilization activity

Country Status (12)

Country Link
EP (2) EP1380304A3 (de)
JP (1) JP2003505412A (de)
AT (1) ATE254452T1 (de)
AU (1) AU777618B2 (de)
CA (1) CA2378650A1 (de)
DE (1) DE60006675T2 (de)
DK (1) DK1196153T3 (de)
ES (1) ES2206276T3 (de)
IL (1) IL147676A0 (de)
IT (1) IT1307787B1 (de)
PT (1) PT1196153E (de)
WO (1) WO2001007021A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4323571B2 (ja) 1997-01-31 2009-09-02 エックスワイ， インコーポレイテッド 光学装置
US6071689A (en) 1997-12-31 2000-06-06 Xy, Inc. System for improving yield of sexed embryos in mammals
US6149867A (en) 1997-12-31 2000-11-21 Xy, Inc. Sheath fluids and collection systems for sex-specific cytometer sorting of sperm
US7208265B1 (en) 1999-11-24 2007-04-24 Xy, Inc. Method of cryopreserving selected sperm cells
US7713687B2 (en) 2000-11-29 2010-05-11 Xy, Inc. System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
CA2822983C (en) 2000-11-29 2017-05-09 Xy, Llc System to separate frozen-thawed spermatozoa into x-chromosome bearing and y-chromosome bearing populations
JP2006500327A (ja) * 2002-07-10 2006-01-05 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 精子の運動性を増大させるための化合物の使用
US8211629B2 (en) 2002-08-01 2012-07-03 Xy, Llc Low pressure sperm cell separation system
US8486618B2 (en) 2002-08-01 2013-07-16 Xy, Llc Heterogeneous inseminate system
CA2534394C (en) 2002-08-15 2013-01-08 Xy, Inc. High resolution flow cytometer
US7169548B2 (en) 2002-09-13 2007-01-30 Xy, Inc. Sperm cell processing and preservation systems
DK2959774T3 (da) 2003-03-28 2019-05-13 Inguran Llc Fremgangsmåde til kryokonservering af sædceller
WO2004104178A2 (en) 2003-05-15 2004-12-02 Xy, Inc. Efficient haploid cell sorting for flow cytometer systems
EP2260854A1 (de) 2004-03-29 2010-12-15 Inguran, LLC Spermasuspensionen zur Sortierung in X- oder Y-Chromosomen-tragende angereicherte Populationen
AU2005266930B2 (en) 2004-07-22 2010-09-16 Inguran, Llc Process for enriching a population of sperm cells
ES2350583T3 (es) * 2005-05-23 2011-01-25 Reckitt Benckiser (Uk) Limited Composición que comprende wortmanina y uso tópico de la misma para reducir el crecimiento del vello humano.
CA2836774C (en) * 2011-05-20 2023-07-04 The Brigham And Women's Hospital, Inc. Analysis and sorting of motile cells
CN113969274A (zh) * 2012-03-16 2022-01-25 生育创新有限公司 精细胞的处理
PT110231B (pt) 2017-08-02 2021-02-22 Universidade Do Porto Potenciadores de mtor e suas utilizações para melhorar a qualidade e função do esperma durante o armazenamento
US10603075B1 (en) 2018-11-30 2020-03-31 Ohana Biosciences, Inc. Compositions and methods for enhancing sperm function
GB202006382D0 (en) 2020-04-30 2020-06-17 Spermatech As Use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4774088A (en) * 1986-01-08 1988-09-27 The United States Of America As Represented By The Deptment Of Health And Human Services Method and additives for improving the quality and shelf life of stored blood
KR920002285B1 (ko) * 1989-10-19 1992-03-21 태평양화학 주식회사 세포 보호제
DE69332451D1 (de) * 1992-03-09 2002-12-05 Univ Washington Methoden zur regulation der früchtbarkeit von pflanzen
US6632789B1 (en) * 1994-04-29 2003-10-14 The United States Of America As Represented By The Secretary Of The Navy Methods for modulating T cell responses by manipulating intracellular signal transduction
JP2991620B2 (ja) * 1994-08-30 1999-12-20 科学技術振興事業団 細胞活動の制御方法
JP2000345724A (ja) * 1999-06-03 2000-12-12 Masafumi Miyamoto アミューズメント施設、アミューズメント施設用コンテナ及びアミューズメント設備の設置方法

Also Published As

Publication number Publication date
ATE254452T1 (de) 2003-12-15
WO2001007021A3 (en) 2001-12-06
EP1380304A3 (de) 2004-07-07
EP1196153B1 (de) 2003-11-19
CA2378650A1 (en) 2001-02-01
ITFI990171A1 (it) 2001-01-26
ES2206276T3 (es) 2004-05-16
WO2001007021A2 (en) 2001-02-01
DE60006675D1 (de) 2003-12-24
EP1196153A2 (de) 2002-04-17
EP1380304A2 (de) 2004-01-14
ITFI990171A0 (it) 1999-07-26
IT1307787B1 (it) 2001-11-19
JP2003505412A (ja) 2003-02-12
AU6159700A (en) 2001-02-13
PT1196153E (pt) 2004-02-27
DE60006675T2 (de) 2004-09-30
AU777618B2 (en) 2004-10-21
DK1196153T3 (da) 2004-01-05

Similar Documents

Publication Publication Date Title
EP1380304A3 (de) Verfahren zur verbesserung der fertilisierenden aktivität von spermatozoa
DE69614105D1 (de) Lagerstabile hämoglobinlösungen
DZ2744A1 (fr) Distribution d'un agent actif aérosolé.
AR015379A1 (es) Ascorbil-fosforil-colesterol
ATE320436T1 (de) Dimere pyrrolobenzodiazepine
DE69626513D1 (en) Imidazolverbindungen
EP0781124A4 (de) Systeme zum transport von wirksubstanzen
NZ516292A (en) Pyrrolotriazine inhibitors of kinases
HUP0103349A3 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
TR199903332T2 (xx) Eletriptan hemis�lfat ve kafein i�eren farmas�tikal bile�ikler.
BG106585A (en) Kinase inhibitors as therapeutic agents
ES2053609T3 (es) Derivados de urea inhibidores de lipoxigenasa.
NZ517758A (en) Pyrazolopyrimidines useful as therapeutic agents
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
WO1999005096A3 (en) Urokinase inhibitors
EP0529854A3 (en) Tetrahydroindazole, tetrahydrocyclopentapyrazole, and hexahydrocycloheptapyrazole compounds and their use as hmg-coa reductase inhibitors
GB9514518D0 (en) Guanidine salt inhibitors of NO synthase and cyclooxygenase
IL139490A0 (en) Phthalazine derivatives as phosphodiesterase 4 inhibitors
DK0724840T3 (da) Fremgangsmåde til forbedring af forplantningsaktiviteten hos orner ved anvendelse af specialfoder for avlsorner
AU2001286242A1 (en) Urea derivative and adhesive-molecule inhibitor containing the same as active ingredient
EP0610519A4 (en) Anti-hiv drug.
AR003418A1 (es) Composición farmacéutica con actividad antiepiléptica que contiene ácido r(-)-n- (4,4-di(3-metiltien-2-il) but-3-enil)-nipecótico o sus sales y el procedimiento para su preparación.
WO2001000189A3 (de) Kombination von mtp-inhibitoren und stoffwechselbeeinflussenden wirkstoffen und ihre verwendung in arzneimitteln
DE69813165T2 (de) Hautdepigmentierungsmittel
ZA922501B (en) Thid-carboxylic acid derivatives as collagenase inhibitors.